Home / Investors / Northpond Ventures

Northpond Ventures

Venture Fund · Bethesda, Maryland · Founded 2018

About Northpond Ventures

Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.

Investment focus

Stages
Sectors

Portfolio (21 in our database)

VestaronVestaron produces insecticides for agriculture, animal health, non-crop, and commercial pest control applications.Series C · $255M raisedPersonal Genome DiagnosticsPersonal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies.Acquired · $245M raisedScipher MedicineScipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.Series D · $227M raisedVizgenVizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.Series C · $136M raisedSherlock BiosciencesSherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.Series B · $136M raisedUltivueUltivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.Series D · $107M raisedAro BiotherapeuticsAro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines.Series A · $101M raisedTriumvira ImmunologicsTriumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.Series A · $100M raisedStrideBioStrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.Series B · $97M raisedSound AgricultureSound Agriculture uses molecular discovery to create climate resilient crops, enhancing harvest yields for growers.Series C · $95M raisedCurrent HealthWe help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.Acquired · $92M raisedCode BiotherapeuticsCode Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.Series A · $85M raisedEleanor HealthEleanor Health provides comprehensive mental health and substance use disorder care in clinics, virtually, and in patient's homes.Series C · $82M raisedEncodiaEncodia is a biotech company that develops the next generation of protein analysis tools.Series C · $75M raised64x Bio64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.Series A · $60M raised18591859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.Series A · $52M raisedTransition BioTransition Bio provides condensate technology for drug discovery and diagnostics.Series A · $50M raisedTotus MedicinesTotus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.Series A · $40M raisedElephasA live tumor imaging diagnostics companySeries A · $27M raisedStory HealthStory Health helps specialists to understand medical situations and make clinical decisions that are through virtual protocols.Series A · $27M raisedScitaraScitara offers a cloud-based connectivity platform that transforms integration between instruments and lab informatics applications.Series B · $22M raised

Similar investors